Development and Validation of Risk Nomogram Model Predicting Coronary Microvascular Obstruction in Patients with ST-Segment Elevation Myocardial Infarction (STEMI) Undergoing Primary Percutaneous Catheterization-Reference-Cited by-同舟云学术

Development and Validation of Risk Nomogram Model Predicting Coronary Microvascular Obstruction in Patients with ST-Segment Elevation Myocardial Infarction (STEMI) Undergoing Primary Percutaneous Catheterization

Published:2019-08-07 Issue: Volume:25 Page:5864-5877
ISSN:1643-3750
Container-title:Medical Science Monitor
language:en
Short-container-title:Med Sci Monit

Author:

Xiao Yuyang¹,Fu Xianghua¹,Wang Yanbo¹,Wu Yanqiang¹,Wang Wenlu¹,Zhang Qian¹

Affiliation:

1. Department of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China (mainland)

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of a diagnostic nomogram in pulmonary hypertension due to left heart disease;Heart & Lung;2024-05

2. A nomogram model for predicting intramyocardial hemorrhage post-PCI based on SYNTAX score and clinical features;BMC Cardiovascular Disorders;2024-03-25

3. Development of a novel tool: a nomogram for predicting in-hospital mortality of patients in intensive care unit after percutaneous coronary intervention;BMC Anesthesiology;2023-01-06

4. Coronary microcirculation dysfunction evaluated by myocardial contrast echocardiography predicts poor prognosis in patients with ST-segment elevation myocardial infarction after percutaneous coronary intervention;BMC Cardiovascular Disorders;2022-12-28

5. Development and Validation of a Clinical and Laboratory-Based Nomogram for Predicting Coronary Microvascular Obstruction in NSTEMI Patients After Primary PCI;Therapeutics and Clinical Risk Management;2022-02